This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: University of California. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mountain View, CA (US) (2015)
- Palo Alto, CA (US) (2019 - 2024)
Company Filing History:
Years Active: 2015-2024
Title: Yafei Hou: Innovator in Glioma Research
Introduction
Yafei Hou is a prominent inventor based in Palo Alto, CA, known for his significant contributions to the field of glioma research. With a total of 5 patents, he has made strides in developing innovative peptides that can generate immune responses to glioma-related proteins.
Latest Patents
Among his latest patents are the H3.3 CTL peptides and their uses. These peptides are designed to elicit an immune response specifically targeting glioma-related H3.3 proteins. The methods associated with these peptides hold promise for advancing treatment options for glioma patients.
Career Highlights
Yafei Hou is affiliated with the University of California, where he continues to push the boundaries of research in immunotherapy. His work has garnered attention for its potential impact on cancer treatment, particularly in the realm of gliomas.
Collaborations
He collaborates with esteemed colleagues, including Hideho Okada and Lawrence Fong, who share his commitment to advancing cancer research and treatment methodologies.
Conclusion
Yafei Hou's innovative work in glioma research exemplifies the critical role of inventors in the medical field. His contributions through patents and collaborations are paving the way for new therapeutic approaches to combat glioma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile